69 related articles for article (PubMed ID: 7939444)
1. Radioimmunoimaging diagnosis of human bladder carcinoma.
Yu LZ; Gu FL; Zhang CL
Scand J Urol Nephrol Suppl; 1994; 157():13-7. PubMed ID: 7939444
[TBL] [Abstract][Full Text] [Related]
2. Targeted diagnosis and treatment of superficial bladder cancer with monoclonal antibody BDI-1.
Yu L; Gu F; Zhang C; Xie S; Guo Y
Chin Med J (Engl); 1998 May; 111(5):404-7. PubMed ID: 10374347
[TBL] [Abstract][Full Text] [Related]
3. [Labeling of antihuman bladder carcinoma monoclonal antibody with a technetium-99m and radioimmunoimaging of human bladder carcinoma xenograft in nude mice].
Samten B; Yu L; Zhang C
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):10-2. PubMed ID: 9275678
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of radioimmunoimaging with 99mTc-BDI-1 in the diagnosis of bladder cancer.
Wang R; Zhang C; Yu L; Guo Y
Chin Med J (Engl); 2000 May; 113(5):396-9. PubMed ID: 11776091
[TBL] [Abstract][Full Text] [Related]
5. [Radioimmunoimaging of bladder tumor with the intravesical administration of technetium -99m labelled monoclonal antibody].
Li N; Yu L; Zhang C
Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):54-6. PubMed ID: 11715544
[TBL] [Abstract][Full Text] [Related]
6. Targeted diagnosis of bladder and ureteral carcinoma using radiolabelled BDI-1.
Zhang CL; Yu LZ; Gu FL; Buka SD; Zu SL; Xie SS; Pan ZY
Urol Res; 1998; 26(5):343-8. PubMed ID: 9840344
[TBL] [Abstract][Full Text] [Related]
7. Tumour localization of radiolabelled monoclonal antibody in mice bearing human urinary bladder (T24) carcinoma xenografts.
Bubeník J; Kieler J; Perlmann P; Paulie S; Koho H; Christensen B; Dienstbier Z; Koprivová H; Pospísil J; Novák F
Folia Biol (Praha); 1985; 31(2):176-84. PubMed ID: 3894060
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoimaging of human bladder tumor xenografts in nude mice by using monoclonal antibodies.
Sakahara H; Endo K; Koizumi M; Nakashima T; Okada K; Yoshida O; Masuko T; Hashimoto Y; Torizuka K
Jpn J Cancer Res; 1986 Sep; 77(9):916-21. PubMed ID: 3095288
[TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder.
Zorzos J; Skarlos DV; Pozatzidou P; Zizi A; Bakiras A; Koritsiadis S; Pectasidis D; Koutsioumba P; Epenetos AA; Likourinas M
Urol Res; 1994; 22(5):323-7. PubMed ID: 7879319
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
[TBL] [Abstract][Full Text] [Related]
11. [Radioimmunoscintigraphy and magnetic resonance tomography in the diagnosis of urinary bladder cancer].
Benz P; Dewes W; Hau U; Becht E; Keweloh C; Ziegler M; Kramann B
Nuklearmedizin; 1992 Jun; 31(3):74-9. PubMed ID: 1641358
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunodetection of human bladder tumor xenografts in nude mice with radiolabeled monoclonal antibodies.
Fradet Y; Friede J; Guertin B; Leclerc J; Dufour C; Caron C
J Urol; 1992 Aug; 148(2 Pt 1):418-22. PubMed ID: 1635152
[TBL] [Abstract][Full Text] [Related]
13. Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancer.
Simms MS; Murray A; Denton G; Scholfield DP; Price MR; Perkins AC; Bishop MC
Urol Res; 2001 Feb; 29(1):13-9. PubMed ID: 11310209
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunodetection of a transplantable human bladder carcinoma in a nude mouse.
Gross MD; Skinner RW; Grossman HB
Invest Radiol; 1984; 19(6):530-4. PubMed ID: 6511260
[TBL] [Abstract][Full Text] [Related]
15. [The study of radioimmunoimaging on the nude mice bearing human ovarian carcinoma by labelling monoclonal antibody with 99mTc].
Lin W; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):308-10. PubMed ID: 9206189
[TBL] [Abstract][Full Text] [Related]
16. [In vitro and in vivo functional evaluation of anti-human bladder tumor human-mouse chimeric antibody ch-BDI].
Bai Y; Yu LZ; Lü YQ; Ai JK; Zhang CL; Ding Y; Wang Y
Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):96-8. PubMed ID: 12783667
[TBL] [Abstract][Full Text] [Related]
17. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
Huland E; Arndt R; Huland H
Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
[TBL] [Abstract][Full Text] [Related]
18. The expression of epidermal growth factor receptor on human bladder cancer: potential use in radioimmunoscintigraphy.
Harney JV; Liebert M; Wedemeyer G; Washington R; Stein J; Buchsbaum D; Steplewski Z; Grossman HB
J Urol; 1991 Jul; 146(1):227-31. PubMed ID: 2056595
[TBL] [Abstract][Full Text] [Related]
19. Immunotargeting with monoclonal cytokeratin 8 antibodies of human urothelial cancer transplanted to nude mice.
Letocha H; Nilsson S; Silén A; Ekblom J; Arnberg H; Wiklund B; Westlin JE
Acta Oncol; 1993; 32(7-8):793-800. PubMed ID: 7508236
[TBL] [Abstract][Full Text] [Related]
20. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
